A lower DCIS Score result means there is a lower chance of any tumor coming back in the same breast (either a DCIS or invasive breast cancer) and of the tumor coming back in the same breast as an invasive breast cancer. A higher score means that there is a higher chance of any tumor coming back in the same breast (either a DCIS or invasive breast cancer) and of the tumor coming back in the same breast as an invasive breast cancer.
The Breast DCIS Score results help guide personalized treatment decisions. Because everyone’s body and tumor are unique, obtaining a DCIS Score result helps make treatment decisions tailored to you.
The Breast DCIS Score provides information in addition to traditional measurements (such as margin width, tumor size and tumor grade) that doctors have traditionally used to estimate how likely a patient’s cancer is to return, and to help them make treatment decisions.
Genomic Health, Inc. (now trading as "Exact Sciences")
Oncotype DX Breast Recurrence Score, Oncotype DX and Recurrence Score are registered trademarks of Genomic Health, Inc.
Exact Sciences is a trademark or registered trademark of Exact Sciences Corporation. ©2020 Genomic Health, Inc. All rights reserved.
Taking into consideration the continuous biology of the DCIS tumor the Breast DCIS Score quantifies:
- the likelihood of local recurrence (DCIS or invasive carcinoma) at 10 years; and,
- predicts specifically the risk of an invasive carcinoma local event at 10 years.
For more information click here.